JPRN-jRCT1040230048招募中Unknown
Single institution study to evaluate the effect of residual solution and additional washings after density gradient centrifugation treatment on sperm findings
Maezawa Tadashi0 个研究点目标入组 40 人开始时间: 2023年6月24日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- >= 18age old 至 ot applicable（—）
- 性别
- Male
入选标准
- •1) Male patients over 18 years old
- •2) Patients whose background can be confirmed in the medical records
- •3) Patients with a total sperm concentration of 2.0 x 10^6 /ml or higher and a motility rate of 40% or higher in the original semen
- •4) Patients who have given written consent to participate in the study.
排除标准
- •1) Those with severe oligozoospermia, severe spermatasthenia, severe hypospermia or azoospermia
- •2) Patients who are deemed inappropriate for inclusion in the study by the principal investigator or research coordinator.
研究者
相似试验
尚未招募
不适用
A study to develop a non pharmacological therapeutic tool to reduce the self stigma in caregivers of people with severe mental illnesses.CTRI/2022/01/039333Dr Tanve Garg
已完成
不适用
A monocenter, non-randomized study to evaluate the clinical relevance of arterial Stenosis to blood flow using a pressure measurement in the affected vessel with the Pressure Wire X from Abbott Vascular.Peripheral artery diseaseI70.2Atherosclerosis of arteries of extremitiesDRKS00022103Medizinische UniversitätsklinikKlinik für Innere Medizin IIIKardiologie, Angiologie und Pneumologie50
已完成
2 期
A multi-institutional study analyzing effect of a novel lozenge containing polaprezinc for patients treated with high dose chemotherapy followed by hematopoietic stem cell transplantatioHematological malignancyJPRN-UMIN000025524Gifu University91
已完成
不适用
To study the effect of Atarax cream in human volunteers with itching.CTRI/2022/03/040739Dr Reddys Laboratories Ltd32
尚未招募
Unknown
High Dose Methotrexate Pharmacokinetics, Pharmacogenomics, Adverse Effects and Clinical Outcomes in Patients with Acute Lymphoblastic LeukaemiaCTRI/2023/07/054865PGIMER